Federal Analysis
U.S. and Canada Promote Domestic Pharmaceutical Manufacturing
March 14, 2026
Government leaders in the United States and Canada are actively advocating for the repatriation and strengthening of domestic pharmaceutical manufacturing to address national security risks posed by reliance on foreign drug supplies, particularly from China. U.S. Senator Tommy Tuberville and witnesses at a Senate Committee on Aging hearing emphasized the need for federal incentives, stronger regulatory enforcement by the FDA, and use of tariffs to stimulate onshore production. Concurrently, Canadian policymakers and industry representatives call for a Canada-first procurement strategy, regulatory prioritization, and defense-aligned investments to build pharmaceutical sovereignty amid geopolitical tensions and trade disputes.
- Why this matters: Procurement professionals should anticipate increased federal funding and contracting opportunities aimed at expanding domestic pharmaceutical manufacturing capacity in both countries.
- Agencies like the FDA and DoD may implement stricter regulatory and sourcing requirements to reduce supply chain vulnerabilities.
- Companies specializing in pharmaceutical manufacturing, supply chain logistics, and regulatory compliance can position themselves to support government initiatives focused on onshoring.
- This trend signals a shift toward procurement policies that prioritize national security considerations in pharmaceutical sourcing and manufacturing.
We need to bring back production here to break China's monopoly on pharmaceutical manufacturing.
— Mr. Chang
We need to put more force on the FDA to regulate and inspect drugs as they do domestically.
— Congressman Yoho
A lot of people would die in this country if China ceased exports of key pharmaceutical materials today.
— Rosemarie Gibson
Agencies
United States Senate, Senate Committee on Aging, Food and Drug Administration, Department of Defense, House Appropriations Committee
Vendors
Oxford Pharmaceuticals
Locations
Sources
- Medicine Security Is National Security: The Case for Canadian Pharmaceutical Sovereignty - The Hill Times · The Hill Times · Mar 14
- Tuberville Advocates for Returning Pharmaceutical Manufacturing to the U.S. ยป Coach Tommy Tuberville · Tuberville Senate · Mar 13